Evaluation of Two Consolidation Regimens in the Treatment of Adult Acute Lymphoblastic Leukemia
Research committees
Publication Information Expand/Collapse
2001
Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group study
2000
Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult a2000 Apr 1;95(7):2364-71.cute lymphoblastic leukemia
1997
Detection of cancer cells with PCR-telomerase assay in human tumor biopsies.
Inactivation of cell cycle regulatory genes occurs frequently in adult acute lymphoblastic leukemia (ALL): potential role for p16, p13, Rb, and p53 in leukemogenesis.
1996
Comparison of tumor suppressor gene inactivation in de novo and relapsed adult acute lymphoblastic leukemia (ALL).
Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies.
1995
Inactivation of tumor suppressor genes, Rb1, and p53, in adult ALL. The Southwest Oncology Group experience.
1994
Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction.
1993
A comparison of two consolidated regimens in the treatment of adult acute lymphoblastic leukemia (ALL): The results of the Southwest Oncology Group studies (SWOG) 8417/19
1992
Expression of myeloid antigens in adult acute lymphoblastic leukemia: The Southwest Oncology Group experience.
1991
Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction.
1990
An outpatient (OP) approach to the delivery of intensive consolidation chemotherapy (CT) to adults with acute lymphoblastic leukemia (ALL).